Bergan Kdv Wealth Management, LLC Albireo Pharma, Inc. Transaction History

Bergan Kdv Wealth Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$27.36 - $35.98 $8,208 - $10,793	-300 Closed	0 $0
Q3 2020 Nov 05, 2020	SELL	$23.19 - $41.61 $1,159 - $2,080	-50 Reduced 14.29%	300 $10,000
Q2 2020 Aug 13, 2020	BUY	$14.82 - $29.92 $2,593 - $5,236	175 Added 100.0%	350 $9,000
Q4 2019 Feb 10, 2020	BUY	$16.92 - $28.96 $2,961 - $5,068	175 New	175 $4,000

865

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

Get notified when there are updates to the investment portfolio of Bergan Kdv Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bergan Kdv Wealth Management, LLC with notifications on news.